EBG00000313339 - n.2101_2104delACCC
Drug resistance types
0 Sensitive
6 RR-TB
0 HR-TB
9 MDR-TB
4 Pre-XDR-TB
0 XDR-TB
8 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.1 | 7 |
| lineage4.8 | 2 |
| lineage2.2.1.1 | 1 |
| lineage4.1.2 | 1 |
| lineage3 | 2 |
| lineage4.9 | 4 |
| lineage4.1.1.1 | 1 |
| lineage4.3.4.2 | 1 |
| lineage4.4.1.1 | 1 |
| lineage4.3.3 | 1 |
| lineage4.3.4.1 | 1 |
| lineage3.1.1 | 1 |
| lineage4.1.2.1 | 1 |
| lineage4.2.1 | 2 |
| lineage2.2;lineage4 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 27 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR16156697 | RR-TB | lineage2.2.1 | None | SRR19303907 | Other | lineage4.8 | None | ERR983238 | MDR-TB | lineage2.2.1.1 | None | ERR10796581 | Other | lineage4.1.2 | None | SRR10303325 | MDR-TB | lineage2.2.1 | None | SRR5341267 | Pre-XDR-TB | lineage3 | None | ERR3797062 | RR-TB | lineage4.9 | None | SRR8758877 | MDR-TB | lineage4.1.1.1 | None | ERR3283006 | RR-TB | lineage4.9 | None | SRR11342673 | RR-TB | lineage4.3.4.2 | None | SRR17567917 | RR-TB | lineage4.4.1.1 | None | SRR11342649 | MDR-TB | lineage4.3.3 | None | ERR2600576 | Pre-XDR-TB | lineage2.2.1 | None | SRR1173719 | Other | lineage4.9 | None | ERR10796618 | Other | lineage4.3.4.1 | None | SRR7131196 | Other | lineage4.8 | None | SRR18003046 | MDR-TB | lineage2.2.1 | None | ERR3283032 | Other | lineage4.9 | None | SRR5341365 | Pre-XDR-TB | lineage3 | None | SRR1173310 | Other | lineage3.1.1 | None | SRR21240055 | Other | lineage4.1.2.1 | None | ERR10762275 | MDR-TB | lineage4.2.1 | None | SRR14782539 | MDR-TB | lineage4.2.1 | None | ERR2600577 | Pre-XDR-TB | lineage2.2.1 | None | SRR10430377 | MDR-TB | lineage2.2.1 | None | SRR18003009 | MDR-TB | lineage2.2.1 | None | SRR16156832 | RR-TB | lineage2.2;lineage4 | None |
|---|
